Frank Gentile

Dr. Frank T.
Gentile is a Chief Executive Officer & Director at Casma Therapeutics, Inc. He is on the Board of Directors at Casma Therapeutics, Inc. and Raven Biotechnologies, Inc. Dr. Gentile was previously employed as a Venture Partner by Third Rock Ventures LLC, a Senior Vice President by Tekla Capital Management LLC, a Vice President-Technology Program Management by Takeda Oncology Co., a Research Analyst by Millennium TVP Management Co. LLC, a Vice President-Program Management by Reprogenesis, Inc., a Vice President-Product Development by Curis, Inc., and a Principal by CytoTherapuetics, Inc. He also served on the board at FlowCardia, Inc., CardioKinetix, Inc., Conor Medsystems LLC, Euthymics Bioscience, Inc., Insightra Medical, Inc., Neurovance, Inc. and Veniti, Inc. He received his undergraduate degree from the The Cooper Union for the Advancement of Science & Art and a doctorate degree from Massachusetts Institute of Technology.